WanJie Tianyuan Redefines the Artificial Ligament Market with Coating Technology Ahead of National Re-tendering
Wanjie Medical
Orthopedic Consumables Manufacturer
Artificial Ligament Continuation Collection Welcomes Key Variables
In 2023, artificial ligaments were included in the national procurement for the first time.Only Two Participants, Overall Decline Approximately 32%, which is considered mild in the high-value consumables centralized procurement. This reflects the long-term highly concentrated market of artificial ligaments with high technical barriers. At that time, there were few approved products in China, and the clinical choice was very limited.
Now, the curtain on the next round of centralized procurement is about to rise, and the market landscape will reach a turning point for reshaping. Beijing Wanjie Medical Device Co., Ltd. (hereinafter referred to as "Wanjie Medical") brings along its...WJ SUPERLIG®Wanjie Medical Artificial Ligament with CoatingOfficially Enter the Market.This product is not onlyThe First Product in China to Pass Through the Special Approval Procedure for Innovative Medical DevicesThe sports medicine artificial ligament product is even moreWorld's First Enhanced Coating Artificial Ligament。
WJ SUPERLIG®Certification of Innovative Results for Wanjie Medical's Coated Artificial Ligament
Its strong entry has completely broken the dual-oligarch pattern in China's artificial ligament market and will also introduce a new technical dimension to the pricing mechanism for centralized procurement and the clinical value evaluation system.
World's First Coated Artificial Ligament, DifferentiatedTechnologyBreakthrough
In clinical practice, traditional artificial ligaments have long faced industry pain points such as susceptibility to wear, weak fixation strength, and poor tissue compatibility.WJ SUPERLIG®Wanjie Medical Artificial Ligament CoatingSurface Modification, Mineralization Coating, Hydrophilic CoatingThree Core Technologies for More Durable and Long-Term Stable Ligament Repair Solutions for Patients with Sports Injuries.
Exclusive Surface Modification Technology, Enhancing Mechanical Properties
The product adopts a high-toughness polyester fiber (PET) body, combined withExclusive Surface Modification Technology, significantly enhancing anti-fatigue performance and mechanical stability, meeting the demands of high-intensity exercise with long-term stable performance.
Mineralized Coating Layer, Dual Enhancement in Fixation Strength and Osseointegration
After traditional PET ligaments are inserted into bone tunnels, they initially rely solely on mechanical compression for fixation, with slow bone integration and a tendency to loosen post-surgery. The product's mineralized coating significantly enhances the contact force between the ligament and the bone screw.Fixed strength increased by 150%, effectively reducing the risk of postoperative loosening. Meanwhile, the coating continuously releases calcium and phosphate ions, activating osteoblast activity and accelerating bone ingrowth.Promote Osseointegration。
Hydrophilic Coating: Reduces Debris, Promotes Tissue Regeneration
Debris particles generated by long-term reciprocating friction of fibers within the joint cavity are an important inducement of late complications after artificial ligament surgery. WJ SUPERLIG®Wanjie Medical's coated artificial ligament constructs a stable hydrophilic microenvironment on the fiber surface, which not only effectivelyReduce the dynamic friction coefficient between fibers and minimize shedding., moreCell Adhesion and ProliferationCreated favorable conditions. Clinical data shows that patients using this product have significantly improved tendon coverage rates, and the risk of rejection reactions has been further reduced.
Compared with autologous ligament transplantation, WJ SUPERLIG®Artificial ligaments demonstrate significant advantages in terms of surgical methods, operation time, and postoperative recovery. They are especially suitable for young athletes, patients who urgently need to restore motor function, and patient groups undergoing revision surgery with no available graft materials.
Currently,WJ SUPERLIG®Wanjie Medical Artificial Ligament with CoatingIt has been serving clinical needs in several top-tier tertiary hospitals. The first batch of indications includes high-difficulty surgeries such as anterior and posterior cruciate ligament reconstruction and knee collateral ligament reconstruction. In the future, the product will gradually expand to repair areas such as acromioclavicular ligaments and foot and ankle ligaments, benefiting more patients.
New Signal of Centralized Procurement:
Coating Technology Initiates Revaluation of Artificial Ligaments
The breakthrough in coating technology has not only achieved a clinical diagnosis and treatment revolution in the field of artificial ligaments but also opened up a new technical evaluation dimension for centralized procurement pricing rules and the clinical value assessment system.
At the beginning of 2026, the National Healthcare Security Administration released the "Medical Insurance Classification and Codes and General Medical Insurance Names for Bone, Cartilage, and Soft Tissue Implantable Medical Consumables," systematically optimizing and adjusting the classification of orthopedic consumables. Under this framework,Artificial ligaments are clearly distinguished by the features of "non-metallic coating" and "no coating.", releasing a clear policy signal:China's national medical insurance authorities recognize that there are substantial differences in technical characteristics and clinical value between coated and non-coated artificial ligaments.
AndDistinguish "Non-Metal Coating/No Coating" in Medical Insurance Coding，This may lay an important groundwork for the grouping logic of subsequent centralized procurement.
In the field of coronary intervention, drug-coated balloons (DCB) have set a precedent. DCBs have obtained independent medical insurance codes and qualified for grouped bidding, with selected prices ranging from 5,000 to 6,000 yuan, while ordinary balloons cost only a few hundred yuan.If the procurement of artificial ligaments follows this model, coated products are expected to gain independent bidding units or a price comparison coefficient bonus.。
And this signal release will have multi-dimensional strategic significance for dealers:
First, the profit is predictable.The First Round of Sports Medicine Centralized Procurement Achieved an Average Price Reduction of 74%, with Anchor Pegs Decreasing by 75%-90%, but Artificial Ligaments Only Dropped by 32%. Under Independent Bidding Protection, the Price System for Coated Products is Expected to Remain Within a Reasonable Range.Secondly, seize the first-mover window period.Wanjie Medical is currently the only coated artificial ligament enterprise to have passed innovative approval, taking the lead in establishing a first-mover advantage.Finally, the certainty of the track direction.Policy-driven price gap incentives will guide the industry from price competition to technology competition, with a focus on the coating sector, anchoring the industry's clear path toward upgrading.
This adjustment of the medical insurance codes, although the detailed rules for centralized procurement grouping have not yet been implemented, has already left ample room for imagination regarding the future direction of the rules for artificial ligament centralized procurement.
Sports Medicine Blue Ocean Racing:
Market Expansion and Policy Boost Spawn New Gold-Mining Opportunities
When selecting products, dealers should not only look at the profit of individual items but also consider the market capacity and growth trends.Sports medicine is currently one of the tracks with guaranteed growth in China's medical device market.
In terms of market volume, the popularization of national sports and the high incidence of sports injuries have driven the continuous expansion of demand. In particular, the large patient population with ACL (anterior cruciate ligament) injuries has a rigid clinical demand. According to Boyan Consulting data,In 2024, the market size of artificial ligaments in China reached 1.87 billion yuan, increasing by 14.6% year-on-year.
After the implementation of centralized procurement, the price of artificial ligaments has significantly dropped, leading to a notable increase in industry penetration. Meanwhile, the volume of arthroscopic surgeries in China maintains steady growth, and sports medicine surgeries continue to expand from tertiary hospitals to secondary hospitals, further broadening the clinical application scenarios for artificial ligaments.In an incremental market landscape, technology-leading enterprises are more likely to capture market share and achieve high-quality growth by leveraging product barriers and clinical advantages.
Wanjie Medical, as a core innovative force in the field, has been deeply engaged since its establishment in 2006.Minimally Invasive Orthopedics and Tissue RegenerationIt is a national high-tech enterprise, a "specialized, refined, novel" small and medium-sized enterprise in Beijing, and has been selected as one of the top 20 in China's medical device R&D comprehensive strength in 2024.
As of now, Wanjie Medical has applied for more than 60 patents of various kinds and has obtained 46 medical device registration certificates.Its core products have achieved full coverage across all 32 provinces in China, with a coverage rate of over 80% in tertiary hospitals.。
Multi-Product Matrix Empowerment
Under the normalization of centralized procurement, supporting solutions and a reasonable profit structure are key factors for dealers in selecting products.Wanjie Medical accurately perceives the needs of distributors,Under its umbrellaCoverageSports Medicine, Spine, Joints, RehabilitationAll orthopedic scenarios, in order to create diversified product solutions, help dealers increase single-hospital output, and enhance customer stickiness.
In the field of sports medicine,WJ SUPERLIG®Wanjie Medical Artificial Ligament with CoatingCombined with the meniscus suture system, a complete diagnosis and treatment plan for knee repair is constructed.For hospital procurement, it is possible to fully equip all consumables for cruciate ligament repair and meniscus repair from the same supplier in one stop, effectively simplifying supply chain management processes and reducing operation and maintenance costs associated with surgical support. For distributors, entering a hospital just once allows for the simultaneous deployment of two product categories, efficiently increasing the business volume of a single hospital and enhancing customer binding.
At the same time,Wanjie Medical has also laid out multiple differentiated core products in the spinal and joint sectors.Among them, the annulus fibrosus suture device is compatible with mainstream minimally invasive spinal surgeries, significantly reducing the risk of recurrence after discectomy. In addition,Wanjie Medical's Wholly-Owned SubsidiaryWanjie Medical's joint antibiotic bone cement and spinal low-viscosity bone cement,Also provides distributors with the opportunity to seize the红利 of domestically produced alternatives.Premium Choice. Currently relatedThe product has obtained CE certification and is simultaneously expanding into overseas markets. The three products cover essential consumables for spine and joint needs, achieving synergistic effects across multiple departments.
From sports medicine to a full range of spine and joint products, Wanjie Medical is leveraging its differentiated product portfolio and comprehensive supporting solutions. While meeting clinical diagnosis and treatment needs, it also opens up a sustainable and profitable cooperation path for distributors.
WJ SUPERLIG® Jieyuan Coated Artificial Ligament
Centralized Procurement Investment Attraction Launched
Dealers Invited to Jointly Explore High-Growth Markets
Currently, Wanjie MedicalThe First Product in China to Pass Through the Special Approval Process for Innovative Medical DevicesThe sports medicine artificial ligament products, with a multi-product portfolio and deep channel empowerment experience, sincerely inviting dealers from all over to jointly explore the high-growth blue ocean market.SelectionWanjie Medical, you will receive:
Differentiated Products Ensure Profit:WJ SUPERLIG®Wanjie Medical Artificial Ligament with CoatingWith innovative approval and dual insurance of medical insurance coding classification, it is expected to gain price protection in the centralized procurement and avoid falling into a price war.
Complete Matrix ExtractionProduction IncreaseExport:Sports Medicine + Spine + Joint Full Department Coverage, Multiple Products in One Order for Increased Volume.
Blue Ocean Track Strong Growth:The sports medicine market maintains rapid growth, and the trend of surgical decentralization continues to expand usage scenarios.
Innovative pipeline has potential:Articular Cartilage Repair Scaffold to Obtain Certification Soon, Securing Continuous Product Competitiveness.
During the centralized procurementGeneration, product selection is selecting the future.WJ SUPERLIG®Wanjie Medical Artificial LigamentIt is a track with a limited time window and clear technical barriers.Wanjie MedicalWe sincerely invite forward-thinking dealer partners to jointly expand the market and achieve dual growth in profits and scale in the new round of centralized procurement.
